Synthetic peptide derived from an internal sequence of Human KIAA0100.
Human breast carcinoma tissue; MCF7 cells.
Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
Preservative: 0.02% Sodium azide Constituents: PBS, 0.88% Sodium chloride, 50% Glycerol Note: PBS (without Mg2+ and Ca2+)
Concentration information loading...
Immunogen affinity purified
ab110911 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
1/100 - 1/500.
Expressed in pancreas, placenta and up-regulated in breast carcinoma epithelial cells, ductal in situ carcinoma (DCIS), invasive breast carcinoma (IBC) and metastatic breast carcinoma cells (MET).
Belongs to the UPF0378 family.
Information by UniProt
Antigen MLAA-22 antibody
Anti-KIAA0100 antibody 图像
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - KIAA0100 antibody (ab110911)
ab110911 at 1/50 dilution staining KIAA0100 in paraffin-embedded Human Breast carcinoma tissue by Immunohistochemistry. The picture on the right is treated with the synthesized peptide.
Immunocytochemistry/ Immunofluorescence - KIAA0100 antibody (ab110911)
ab110911 at 1/100 dilution staining KIAA0100 in MCF7 cells by Immunofluorescence. The picture on the right is treated with the synthesized peptide.
Anti-KIAA0100 antibody (ab110911)参考文献
This product has been referenced in:
et al. High levels of BCOX1 expression are associated with poor prognosis in patients with invasive ductal carcinomas of the breast. PLoS One 9:e86952 (2014).
Read more (PubMed: 24489812) »
See 1 Publication
for this product
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"